Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Schedule your consultation A simple boost for busy weeks
Studies have shown that IL-17A downregulates the expression of downstream target genes in the Wnt/-catenin signalling pathway, such as AXIN2 and CCND1, in osteoblasts and osteocytes, leading to bone loss by inhibiting the activity of osteoblasts and osteocytes
One caution about how to read this table: proportional measurement error falls as the drawn volume rises, but that is a statement about the syringe, not about the peptide
140,155 Other bone diseases related to the Wnt/-catenin signalling pathway Psoriasis is an inflammatory skin disease mediated by elevated IL-17A levels in patient serum
US$ 22.25
US$ 28.21
US$ 23.67
US$ 23.08
US$ 21.96
